the aid library

LIST OPTIONS

Filter

8602

Untangling the Web of Antiretroviral Price Reductions. 18th edition

MSF Access Campaign Médecins Sans Frontières (2016) C3

This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand... more

Download (409)

View PDF (642)

Monitoring food security in countries with conflict situations

FAO, WFP (2018)

A joint FAO/WFP update for the United Nations Security Council, January 2018. ISSUE N.3. Six months on from the last joint report for the United Nations Security Council (UNSC), this report by the Food and Agriculture Organization of the United Nations (FAO) and the World Food Programme (WFP) ... more

Download (396)

View PDF (514)

Uterotonics for the prevention of postpartum haemorrhage
recommended

World Health Organization WHO (2018) C_WHO

WHO Recommendations 2018 Update The primary audience for these recommendations includes health professionals who are responsible for developing national and local health care guidelines and protocols (particularly those related to PPH prevention and treatment) and those involved in the provision of... more

Download (193)

View PDF (194)

Orientaciones sobre la bioseguridad en el laboratorio relacionada con la COVID-19
recommended

Organización Mundial de la Salud OMS (2021) C_WHO

The latest update (28 January 2021) includes the following addition and revision: biosafety aspects for working with antigen-detecting rapid diagnostic test; handling new variants of SARS-CoV-2 in the laboratory; updated assay decontamination before disposal; personal protectiv... more

Download (234)

View PDF (231)

Infection prevention and control guidance for long-term care facilities in the context of COVID-19: interim guidance, 8 January 2021 (Arabic Version)

World Health Organization WHO (2021) C_WHO

This document is an update of the guidance published on 21 March 2020 and contains new evidence and guidance.

Download (1397)

View PDF (3961)

Recommendations for management of common childhood conditions
recommended

World Health Organization (2012)

Evidence for technical update of pocket book recommendations. Newborn conditions, dysentery, pneumonia, oxygen use and delivery, common causes of fever, severe acute malnutrition and supportive care

Download (161)

View PDF (172)

Informe de situación COVID-19 OPS/OMS Argentina: 10 de febrero del 2022

Organización Mundial de la Salud OMS OPS (2022) C_WHO

COVID-19 Situation Update OPS/WHO Argentina: 10 February 2022 Situation report generated by the OPS/WHO representation in Argentina

External Link

Patient education: Coronavirus disease 2019 (COVID-19) and children (The Basics)

Wolters Kluwer; UpToDate (2020) C2

This topic last updated: Apr 28, 2020. The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or condi... more

Download (938)

View PDF (2100)

Guidelines for the programmatic management of drug-resistant tuberculosis

World Health Organization (2011) C_WHO

This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and e... more

Download (510)

View PDF (902)

Zika causality statement

World Health Organization WHO (2016) C_WHO

Zika virus infection: update on the evidence for a causal link to congenital brain abnormalities and Guillain-Barré syndrome Update 7 September 2016

External Link

Patient education: Coronavirus disease 2019 (COVID-19) overview (The Basics)

Wolters Kluwer; UpToDate (2020) C2

Download (1122)

View PDF (1280)

Ebola Virus Disease: Personal Protective Equipment, UNICEF Specifications (March 2015)

UNICEF (2015)

UNICEF provides a detailed update and list of Ebola virus disease personal protective equipment technical specifications for use in high- and low-risk settings. It includes barriers for full body protection, as well as the head, nose, mouth, eyes, hands and feet. In selecting the right PPE specifica... more

Download (717)

View PDF (1329)

Guidelines for malaria vector control
recommended

World Health Organization WHO (2019) C_WHO

these guidelines are updated on 16 February 2021 Please check the new guideline here https://medbox.org/document/who-guidelines-for-malaria#GO

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (573)

View PDF (1181)

International technical guidance on sexuality education. An evidence-informed approach.

UNESCO (2018) CC

This revised and fully updated edition of the International technical guidance on sexuality education benefits from a new review of the current evidence, and reaffirms the position of sexuality education within a framework of human rights and gender equality. It promotes structured learning about... more

External Link

Comprehensive COVID-19 Slideset: Symptoms and Clinical Manifestations

Clinical Care Options (2021) CC

26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.

Download (225)

View PDF (316)

Rwanda Poverty Profile Report, 2013/14 - Integrated Household Living Conditions Survey

National Institute of Statistics of Rwanda (NISR) (2015) C2

This report provides an update on the level of poverty based on 2013/14 Integrated Household Living Conditions Survey (EICV4) focusing on poverty as measured in consumption terms. The report also highlights other trend dimensions of living conditions captured in other surveys that complement and pro... more

External Link

COVID-19 Vaccine Roll Outs in ASEAN & Asia – Live Updates by Country

Asean Briefing (2021) CC

It will be updated continuously. Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations. Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in... more